Stephen Turner, Founder and CEO of Protea Biosciences, Inc., has 30 years of experience in the biotechnology industry, during which time he founded and served as CEO of the BRL division of Life Technologies/Invitrogen, Oncor, OncorMed and Quorum Sciences. He has in-licensed and commercialized technology from over 60 universities worldwide, and he has completed numerous public and private financings. Prior to undertaking his career as a builder of biotechnology companies, he served as Director of Marketing for the clinical microbiology division of Becton, Dickinson & Co., a major health care company.
Interview with the CEO and Chairman: Protea Biosciences Group, Inc. (OTCBB:PRGB)
October 23, 2015
Protea Biosciences, Inc. - Stephen Turner
November 15, 2010
